Massive italian study tracks Real-World use of Cholesterol-Lowering injections

NCT ID NCT05430828

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is following 5,000 Italian patients who are taking PCSK9 inhibitor injections (Repatha or Praluent) for high cholesterol. Researchers want to see how consistently patients take their medication and how well it lowers their LDL cholesterol in real life, not just in a lab. The study will also track side effects and look at differences by age, sex, and other factors.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
PCSK9 inhibitors (evolocumab and alirocumab) given as injections
What this could lead to
If successful, this study could show how well these cholesterol-lowering drugs work in everyday use and help doctors improve treatment plans.
What could go wrong
This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may not apply outside Italy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERCHOLESTEROLEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hypercholesterolemia hyperlipidemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AORN dei Colli - Ospedale monaldi

    RECRUITING

    Naples, 80131, Italy

  • ASST Grande Ospedale Metropolitano Niguarda

    RECRUITING

    Milan, 20162, Italy

  • Azienda Ospedaliera Ordine Mauriziano Torino

    RECRUITING

    Torino, 10128, Italy

  • Azienda Ospedaliera San Camillo-Forlanini

    RECRUITING

    Roma, 00152, Italy

  • Azienda Ospedaliera Universitaria San Giovanni di Dio e Ruggi d'Aragona

    RECRUITING

    Salerno, 84131, Italy

  • Azienda Ospedaliero-Univeristaria di Parma

    RECRUITING

    Parma, 43126, Italy

  • Azienda Ospedaliero-Universitaria "Maggiore della Carità"

    RECRUITING

    Novara, 28100, Italy

  • Federico II University of Naples, Department of Advanced Biomedical Sciences

    RECRUITING

    Naples, 80131, Italy

  • Federico II University of Naples, Department of Translational Medical Sciences

    RECRUITING

    Naples, 80131, Italy

  • Ospedale SS Annunziata A.O.U.

    RECRUITING

    Sassari, 07100, Italy

  • Ospedale di Lecce

    RECRUITING

    Lecce, 73100, Italy

  • Ospedale di Rivoli

    RECRUITING

    Rivoli, 10098, Italy

  • Ospedali dell'Ovest Vicentino

    RECRUITING

    Arzignano, 36071, Italy

  • Policlinico Casilino

    RECRUITING

    Roma, 00169, Italy

  • Policlinico Riuniti Foggia

    RECRUITING

    Foggia, 71122, Italy

  • Policlinico Tor Vergata

    RECRUITING

    Roma, 00133, Italy

  • Policlinico di Milano Ospedale Maggiore - Fondazione IRCCS Ca' Granda

    RECRUITING

    Milan, 20122, Italy

  • Presidio Ospedaliero Maria SS Addolorata

    RECRUITING

    Eboli, 84025, Italy

  • Presidio Ospedaliero Pescara

    RECRUITING

    Pescara, 65124, Italy

  • Sapienza University of Rome

    WITHDRAWN

    Roma, 00185, Italy

  • University Magna Graecia of Catanzaro

    RECRUITING

    Catanzaro, 88100, Italy

  • University of Bari Aldo Moro

    RECRUITING

    Bari, 70121, Italy

  • University of Campania Luigi Vanvitelli

    RECRUITING

    Caserta, 81100, Italy

  • University of Naples Federico II, Department of Clinical Medicine and Surgery

    RECRUITING

    Naples, 80131, Italy

  • University of Siena

    RECRUITING

    Siena, 53100, Italy

  • Università degli Studi di Genova

    RECRUITING

    Genova, 16126, Italy

  • Università degli Studi di Messina

    RECRUITING

    Messina, 98122, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.